The Global CEO Initiative on Alzheimer’s Disease Publishes Landmark Recommendations for Integrating Alzheimer’s Blood Tests into Primary and Secondary Care Settings Across the US
08. Oktober 2024 03:36 ET
|
The Global CEO Initiative on Alzheimer's Disease
Philadelphia, Pennsylvania, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer’s Disease (CEOi) is thrilled to announce the peer-reviewed publication of two companion...
The Global CEO Initiative on Alzheimer’s Disease Publishes the First Performance Recommendations for Blood-Based Biomarker Tests by Experts in the Field
12. Juni 2024 09:10 ET
|
The Global CEO Initiative on Alzheimer's Disease
Philadelphia, Pennsylvania, June 12, 2024 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer’s Disease (CEOi), convened by UsAgainstAlzheimer’s, is proud to announce the peer-reviewed...
Global Leaders in Dementia Meet to Stop Alzheimer's by 2025
17. Dezember 2015 14:36 ET
|
The Global CEO Initiative on Alzheimer's Disease
LAUSANNE, Switzerland, Dec. 17, 2015 (GLOBE NEWSWIRE) -- On December 15-16, experts convened in Lausanne to define an action plan to speed effective treatments and diagnostics for Alzheimer's disease...
Axovant Sciences Joins the Global CEO Initiative on Alzheimer's Disease
13. Oktober 2015 11:54 ET
|
The Global CEO Initiative on Alzheimer's Disease
WASHINGTON, Oct. 13, 2015 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer's Disease (CEOi) today announced that Axovant Sciences will join the CEOi as part of its ongoing effort to advance...
GAP and IMI to Sign MOU to Accelerate Alzheimer's Drug Development
19. März 2015 09:57 ET
|
The Global CEO Initiative on Alzheimer's Disease
WASHINGTON and NICE, FRANCE, March 19, 2015 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform (GAP) and the Innovative Medicines Initiative (IMI) announced today that they will sign a Memorandum of...
Global CEO Initiative on Alzheimer's Disease (CEOi) Launches Program to Harness Power of Big Data, Accelerating Pace of Alzheimer's Research
25. Februar 2015 09:46 ET
|
The Global CEO Initiative on Alzheimer's Disease
WASHINGTON, Feb. 25, 2015 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer's Disease (CEOi) has developed an innovative research initiative with the potential to bring new evidence and...